top of page

AGTC Genomics Brings Earlier Disease Detection to Da Nang Summit and Introduces Epigenetic and Gut Health Healthy Ageing

5 days ago
2 min read

Chief Scientist Dr. Tan Boon Shing joined a panel on how biomarkers and everyday habits can inform earlier decisions about brain and metabolic health.
Chief Scientist Dr. Tan Boon Shing joined a panel on how biomarkers and everyday habits can inform earlier decisions about brain and metabolic health.

DA NANG, VIETNAM — AGTC Genomics brought the science of epigenomics and the gut microbiome to the Da Nang Longevity Summit 2026, highlighting what these fields can teach us about ageing and how they could inform preventive care. The discussion centred on a practical question for longevity medicine. How can people and their healthcare teams act earlier to help preserve memory, mobility and independence as they age?


Dr. Tan Boon Shing, Chief Scientist of AGTC Genomics, joined the panel “Healthy Brain, Healthy Metabolism: From Risk to Resilience — What Can We Do Earlier?” on 13 November at Furama Resort Danang. Moderated by Dr. Thuy Le, the session explored how biomarkers and everyday choices around nutrition, physical activity and sleep can inform earlier decisions about metabolic and cognitive health. AGTC Genomics also participated as a strategic exhibition partner.


What epigenomics and gut health can tell us about ageing


Epigenomics examines the chemical marks that help regulate how cells use DNA. Some of these marks, including those known as DNA methylation, change in measurable patterns as people age. Researchers use those patterns to develop “epigenetic clocks” that estimate aspects of biological ageing. An important question for longevity medicine is whether these measurements can reliably track changes in health over time and help evaluate the effects of preventive interventions.


The gut microbiome offers another window into healthy ageing. Gut microbes help break down dietary fibre and produce compounds that interact with the immune system and influence metabolism. Studies have found differences in gut microbial patterns among older adults with different health outcomes, while controlled dietary research shows that changes in what people eat can alter the composition or activity of their gut microbes. Researchers are still determining which of those changes have lasting benefits for health.


In practice, earlier action can start with a familiar measure. A rise in blood sugar over time can prompt a conversation about nutrition, physical activity and follow-up before symptoms appear. Epigenomic and microbiome research is exploring what additional information could help clinicians make those conversations more personalised. For AGTC Genomics, the goal is to connect advances in measurement with decisions that help people stay healthier for longer.



About AGTC Genomics


AGTC Genomics Sdn. Bhd. is a Malaysian precision medicine and molecular diagnostics company headquartered in Bukit Jalil, Kuala Lumpur. It works with clinicians, hospitals and research institutions across Southeast Asia to make genomic testing more accessible and affordable. Its laboratory is accredited by the College of American Pathologists and holds MS ISO 15189:2022 accreditation for molecular testing within its accredited scope. The company provides clinical genomics services and supports research in microbiome sequencing, DNA methylation profiling, multi-omics and bioinformatics.



 
 
 

Comments


bottom of page